Entity

Time filter

Source Type

Cambridge, MA, United States

Patent
Momenta Pharmaceuticals Inc. | Date: 2015-09-09

The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.


Patent
Momenta Pharmaceuticals Inc. | Date: 2015-10-14

The invention provides methods, databases and systems for making glycoprotein products having defined properties.


The present invention provides methods of evaluating CHO cells.


Patent
Momenta Pharmaceuticals Inc. | Date: 2015-11-13

Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.


Patent
Momenta Pharmaceuticals Inc. | Date: 2015-03-25

The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.

Discover hidden collaborations